Rodés J - Search Results

1

Sodium fluoride prevents bone loss in primary biliary cirrhosis.

Guañabens N, Parés A, del Rio L, Roca M, Gómez R, Muñoz J, Rodés J. Guañabens N, et al. Among authors: rodes j. J Hepatol. 1992 Jul;15(3):345-9. doi: 10.1016/0168-8278(92)90066-x. J Hepatol. 1992. PMID: 1447501 Clinical Trial.

2

Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.

Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S, Rivera F, Rodés J. Guañabens N, et al. Among authors: rodes j. Am J Gastroenterol. 1990 Oct;85(10):1356-62. Am J Gastroenterol. 1990. PMID: 2220729

3

Esophageal dysfunction in primary biliary cirrhosis.

Parés A, Grande L, Bruix J, Pera C, Rodés J. Parés A, et al. Among authors: rodes j. J Hepatol. 1988 Dec;7(3):362-7. doi: 10.1016/s0168-8278(88)80009-6. J Hepatol. 1988. PMID: 3235802

4

Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis.

Lozano F, Parés A, Borche L, Plana M, Gallart T, Rodés J, Vives J. Lozano F, et al. Among authors: rodes j. Hepatology. 1988 Jul-Aug;8(4):930-8. doi: 10.1002/hep.1840080438. Hepatology. 1988. PMID: 3292364

5

Portal hypertension in primary biliary cirrhosis. Relationship with histological features.

Navasa M, Parés A, Bruguera M, Caballería J, Bosch J, Rodés J. Navasa M, et al. Among authors: rodes j. J Hepatol. 1987 Dec;5(3):292-8. doi: 10.1016/s0168-8278(87)80035-1. J Hepatol. 1987. PMID: 3429837

6

Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis.

Vilagut L, Vila J, Viñas O, Parés A, Ginés A, Jiménez de Anta MT, Rodés J. Vilagut L, et al. Among authors: rodes j. J Hepatol. 1994 Oct;21(4):673-7. doi: 10.1016/s0168-8278(94)80117-7. J Hepatol. 1994. PMID: 7529275

7

Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis.

Guañabens N, Parés A, Navasa M, Martínez de Osaba MJ, Hernández ME, Muñoz J, Rodés J. Guañabens N, et al. Among authors: rodes j. J Hepatol. 1994 Jul;21(1):24-8. doi: 10.1016/s0168-8278(94)80132-0. J Hepatol. 1994. PMID: 7963418 Clinical Trial.

8

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.

Guañabens N, Parés A, Monegal A, Peris P, Pons F, Alvarez L, de Osaba MJ, Roca M, Torra M, Rodés J. Guañabens N, et al. Among authors: rodes j. Gastroenterology. 1997 Jul;113(1):219-24. doi: 10.1016/s0016-5085(97)70098-2. Gastroenterology. 1997. PMID: 9207281 Clinical Trial.

9

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

Parés A, Planas R, Torres M, Caballería J, Viver JM, Acero D, Panés J, Rigau J, Santos J, Rodés J. Parés A, et al. Among authors: rodes j. J Hepatol. 1998 Apr;28(4):615-21. doi: 10.1016/s0168-8278(98)80285-7. J Hepatol. 1998. PMID: 9566830 Clinical Trial.

10

Guañabens N, Parés A, Alvarez L, Martínez de Osaba MJ, Monegal A, Peris P, Ballesta AM, Rodés J. Guañabens N, et al. Among authors: rodes j. J Bone Miner Res. 1998 Apr;13(4):731-8. doi: 10.1359/jbmr.1998.13.4.731. J Bone Miner Res. 1998. PMID: 9580479 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters